| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d0446a5bd77c7da68216fc2e3f05d48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_766eae8ff319d5744cdadf9b32cf8baa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff00c9b919a7efd7f7df2ea02ed6b0ea |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2006-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33625091dc9e63054b40d7fcef20dac9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09fe04e86c69a7a202b8a118a3158f7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1db1af908e60b8b9f4de971d778a217a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8339a0aa3b3337ef9d302e53cd44639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eedd12316bb70674469552132f4a3a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_948e9c23df25c9e5073e45c746ccd3ff |
| publicationDate |
2006-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2610838-A1 |
| titleOfInvention |
Novel salts of conjugated psychotropic drugs and processes of preparing same |
| abstract |
Novel chemical conjugates of a psychotropic drug residue and an amino-containing organic acid residue selected to reduce side effects induced by the psychotropic drug when administered per se, to enhance the therapeutic activity of the psychotropic drug and/or to exert anti-proliferative activity, in which the amino group is in the form of an acid addition salt thereof and which are characterized by high stability are disclosed. Further disclosed are processes for preparing the chemical conjugates and addition salts thereof, pharmaceutical compositions containing the chemical conjugates and methods utilizing the chemical conjugates for treating various medical conditions. |
| priorityDate |
2005-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |